Die Fundamentaldaten des Unternehmens sind relativ schwach. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Kaufen bewertet. Trotz einer schwachen Aktienmarktperformance zeigt das Unternehmen starke Fundamentaldaten und technische Indikatoren. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Aktienbewertung
Zugehörige Informationen
Branchenrang
109 / 474
Gesamtwertung
195 / 4754
Branche
Software & IT-Dienstleistungen
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
3
Analysten
Kaufen
Aktuelles Rating
8.583
Kursziel
+65.06%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Unternehmens-Highlights
HöhepunkteRisiko
Blade Air Mobility, Inc. provides air transportation and logistics for hospitals across the United States. The Company transports human organs for transplant, and for passengers, with helicopter and fixed wing services primarily in the Northeast United States, Southern Europe and Western Canada. The Company's segments include Passenger and Medical. Its Passenger segment includes Short Distance and Jet and Other. Short Distance business consists primarily of helicopter and amphibious seaplane flights in the United States, Canada and Europe. Jet and Other business consist principally of non-medical jet charter and by-the-seat jet flights between New York and South Florida. Its Medical segment includes MediMobility Organ Transport, which consists primarily of transportation of human organs for transplant and/or the medical teams supporting these services. It also offers additional services including donor logistics coordination and support for evaluating potential donor organs.
Blade Air Mobility, Inc. provides air transportation and logistics for hospitals across the United States. The Company transports human organs for transplant, and for passengers, with helicopter and fixed wing services primarily in the Northeast United States, Southern Europe and Western Canada. The Company's segments include Passenger and Medical. Its Passenger segment includes Short Distance and Jet and Other. Short Distance business consists primarily of helicopter and amphibious seaplane flights in the United States, Canada and Europe. Jet and Other business consist principally of non-medical jet charter and by-the-seat jet flights between New York and South Florida. Its Medical segment includes MediMobility Organ Transport, which consists primarily of transportation of human organs for transplant and/or the medical teams supporting these services. It also offers additional services including donor logistics coordination and support for evaluating potential donor organs.